Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Biotechnology Equipment

PUBLISHER: TechSci Research | PRODUCT CODE: 1703336

Cover Image

PUBLISHER: TechSci Research | PRODUCT CODE: 1703336

Fluorescent In Situ Hybridization Probe Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Technology, By Type (DNA, RNA ), By Application, By End-Use, By Region, & Competition, 2020-2030F

PUBLISHED:
PAGES: 186 Pages
DELIVERY TIME: 2-3 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4500
PDF and Excel (Multi-User License)
USD 5500
PDF and Excel (Custom Research License)
USD 8000

Add to Cart

We offer 8 hour analyst time for an additional research. Please contact us for the details.

Description

Table of Contents

Global Fluorescent In Situ Hybridization Probe Market was valued at USD 981.50 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 6.45% through 2030. The Global Fluorescent In Situ Hybridization (FISH) Probe Market is undergoing rapid expansion, fueled by the rising demand for high-precision genomic diagnostics across oncology, rare disease research, and cytogenetics. This market encompasses the development, manufacturing, and commercialization of FISH probes specialized molecular tools designed to detect and localize specific DNA or RNA sequences within intact cells or tissue samples.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 981.50 Million
Market Size 2030USD 1431.41 Million
CAGR 2025-20306.45%
Fastest Growing SegmentFLOW-FISH
Largest MarketNorth America

These probes are essential for identifying chromosomal abnormalities, gene amplifications, deletions, or translocations, making them indispensable in both clinical diagnostics and translational research. In oncology, FISH probes are routinely deployed to support targeted therapy decisions, such as identifying HER2 gene amplification in breast cancer or ALK gene rearrangements in lung cancer. Their role is equally critical in prenatal diagnostics, hematologic malignancy evaluation, and in validating results from next-generation sequencing platforms.

Market growth is also being driven by increased adoption in academic and pharmaceutical R&D, particularly as precision medicine and biomarker-based drug development gain traction. Further, the integration of automated imaging systems with AI-driven interpretation is accelerating throughput and reducing analysis time, enhancing the clinical utility and commercial viability of FISH-based assays.

Key Market Drivers

Advancements in Genomic Research

Advancements in genomic research have revolutionized our understanding of genetics, enabling breakthroughs in disease diagnosis, treatment, and prevention. One of the key technologies driving progress in this field is Fluorescent In Situ Hybridization (FISH), which allows researchers to visualize and locate specific DNA sequences within cells. As genomic research continues to evolve, so does the demand for FISH probes, making them a pivotal component of the Global FISH Probe Market. The sequencing of the human genome marked a monumental achievement in the field of genomics. It provided researchers with a comprehensive map of our genetic makeup, comprising over 20,000 protein-coding genes. However, understanding the functions and interactions of these genes requires tools like FISH probes to visualize their activity within cells. As genomics delves deeper into gene function, the demand for FISH probes increases. Genomic research has been instrumental in identifying genetic mutations that cause diseases. Whether it's rare genetic disorders or common ailments like cancer, researchers are increasingly using FISH probes to pinpoint specific mutations within the genome. This has significant implications for diagnosis, prognosis, and targeted therapies, driving the need for more advanced FISH probes. Advancements in genomics have ushered in the era of personalized medicine. By analyzing an individual's genetic profile, clinicians can tailor treatments to a patient's unique genetic makeup. FISH probes play a critical role in this process by helping identify specific genetic markers and abnormalities.

As personalized medicine gains traction, so does the demand for FISH probes that enable precise genetic analysis. Genomic research has revealed the genetic underpinnings of complex diseases like Alzheimer's, diabetes, and heart disease. Investigating these conditions often requires an in-depth understanding of genetic variations and gene expression patterns. FISH probes provide researchers with the tools to study these complexities at the cellular level, advancing our knowledge of disease mechanisms and potential therapeutic targets. The pharmaceutical industry heavily relies on genomic research to discover new drug targets and develop precision medicines. FISH probes are essential in validating potential drug targets by confirming the presence or absence of specific genetic markers in cellular models. This accelerates drug development and fuels the demand for FISH probes in research and development. Both academic research institutions and clinical laboratories benefit from advancements in genomics. Researchers in these settings use FISH probes for a wide range of applications, from studying basic biological processes to diagnosing genetic disorders. As research expands and diversifies, so does the market for FISH probes.

Key Market Challenges

Competitive Market Dynamics

Competition in the FISH Probe Market is fierce, with several major players and numerous smaller companies vying for market share. This competition can lead to price wars and pressure on profit margins. Differentiating products becomes crucial in this environment.

Key Market Trends

Expanding Applications in Non-Invasive Prenatal Testing (NIPT)

Non-invasive prenatal testing (NIPT) is revolutionizing prenatal care by allowing the detection of fetal chromosomal abnormalities through a simple blood test. FISH probes are becoming increasingly important in NIPT, enabling the identification of specific chromosomal disorders. The expansion of NIPT applications is expected to drive down the demand for FISH probes.

Key Market Players

  • Thermo Fisher Scientific Inc.
  • PerkinElmer Health Sciences Inc
  • Biodot Inc
  • New Horizons Diagnostic Corp
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Abnova Corp.
  • Genemed Biotechnologies Inc
  • F. Hoffmann-La Roche Ltd
  • Oxford Gene Technology Ltd

Report Scope:

In this report, the Global Fluorescent In Situ Hybridization Probe Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fluorescent In Situ Hybridization Probe Market, By Technology:

  • Q FISH
  • FLOW FISH
  • Others

Fluorescent In Situ Hybridization Probe Market, By Type:

  • DNA
  • RNA
    • mRNA
    • miRNA
    • Others

Fluorescent In Situ Hybridization Probe Market, By Application:

  • Cancer Research
  • Genetic Diseases
  • Others

Fluorescent In Situ Hybridization Probe Market, By End-Use:

  • Research
  • Clinical
  • Companion Diagnostics

Fluorescent In Situ Hybridization Probe Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fluorescent In Situ Hybridization Probe Market.

Available Customizations:

Global Fluorescent In Situ Hybridization Probe market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Show more
Product Code: 16616

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Fluorescent In Situ Hybridization Probe Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technology (Q FISH, FLOW FISH, Others)
    • 5.2.2. By Type (DNA, RNA (mRNA, miRNA, Others))
    • 5.2.3. By Application (Cancer Research, Genetic Diseases, Others)
    • 5.2.4. By End-Use (Research, Clinical, Companion Diagnostics)
    • 5.2.5. By Region
    • 5.2.6. By Company (2024)
  • 5.3. Product Market Map

6. North America Fluorescent In Situ Hybridization Probe Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technology
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By End-Use
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fluorescent In Situ Hybridization Probe Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Technology
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By End-Use
    • 6.3.2. Canada Fluorescent In Situ Hybridization Probe Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Technology
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By End-Use
    • 6.3.3. Mexico Fluorescent In Situ Hybridization Probe Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Technology
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By End-Use

7. Europe Fluorescent In Situ Hybridization Probe Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technology
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By End-Use
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Technology
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By End-Use
    • 7.3.2. United Kingdom Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Technology
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By End-Use
    • 7.3.3. France Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Technology
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By End-Use
    • 7.3.4. Italy Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Technology
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By End-Use
    • 7.3.5. Spain Fluorescent In Situ Hybridization Probe Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Technology
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By End-Use

8. Asia-Pacific Fluorescent In Situ Hybridization Probe Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technology
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By End-Use
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Technology
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By End-Use
    • 8.3.2. Japan Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Technology
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By End-Use
    • 8.3.3. India Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Technology
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By End-Use
    • 8.3.4. Australia Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Technology
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By End-Use
    • 8.3.5. South Korea Fluorescent In Situ Hybridization Probe Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Technology
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By End-Use

9. South America Fluorescent In Situ Hybridization Probe Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technology
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By End-Use
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fluorescent In Situ Hybridization Probe Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Technology
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By End-Use
    • 9.3.2. Argentina Fluorescent In Situ Hybridization Probe Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Technology
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By End-Use
    • 9.3.3. Colombia Fluorescent In Situ Hybridization Probe Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Technology
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By End-Use

10. Middle East and Africa Fluorescent In Situ Hybridization Probe Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Technology
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By End-Use
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Technology
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By End-Use
    • 10.3.2. Saudi Arabia Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Technology
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By End-Use
    • 10.3.3. UAE Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Technology
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By End-Use
    • 10.3.4. Kuwait Fluorescent In Situ Hybridization Probe Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Technology
        • 10.3.4.2.2. By Type
        • 10.3.4.2.3. By Application
        • 10.3.4.2.4. By End-Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Thermo Fisher Scientific Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Product & Service Offerings
    • 14.1.3. Recent Developments
    • 14.1.4. Financials (If Listed)
    • 14.1.5. Key Personnel
    • 14.1.6. SWOT Analysis
  • 14.2. PerkinElmer Health Sciences Inc
  • 14.3. Biodot Inc
  • 14.4. New Horizons Diagnostic Corp
  • 14.5. Merck KGaA
  • 14.6. Agilent Technologies, Inc.
  • 14.7. Abnova Corp.
  • 14.8. Genemed Biotechnologies Inc
  • 14.9. F. Hoffmann-La Roche Ltd
  • 14.10. Oxford Gene Technology Ltd

15. Strategic Recommendations

16. About Us & Disclaimer

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!